Literature DB >> 10981140

Pathophysiology of obesity hypertension.

J E Hall1.   

Abstract

Excess weight gain is a major cause of essential hypertension, and abnormal kidney function appears to be a cause as well as a consequence of obesity hypertension. Excess renal sodium reabsorption and a hypertensive shift of pressure natriuresis play a major role in mediating increased blood pressure associated with weight gain. Activation of the renin-angiotensin and sympathetic nervous systems and physical compression of the kidneys appear to contribute to obesity-induced increases in sodium reabsorption and hypertension.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10981140     DOI: 10.1007/s11906-000-0073-4

Source DB:  PubMed          Journal:  Curr Hypertens Rep        ISSN: 1522-6417            Impact factor:   5.369


  35 in total

1.  Interactions between the melanocortin system and leptin in control of sympathetic nerve traffic.

Authors:  W G Haynes; D A Morgan; A Djalali; W I Sivitz; A L Mark
Journal:  Hypertension       Date:  1999-01       Impact factor: 10.190

2.  Antihypertensive effect of alpha- and beta-adrenergic blockade in obese and lean hypertensive subjects.

Authors:  M R Wofford; D C Anderson; C A Brown; D W Jones; M E Miller; J E Hall
Journal:  Am J Hypertens       Date:  2001-07       Impact factor: 2.689

3.  Hyperinsulinemia: a link between obesity and hypertension?

Authors:  J E Hall
Journal:  Kidney Int       Date:  1993-06       Impact factor: 10.612

4.  Diastolic compliance is reduced in obese rabbits.

Authors:  J F Carroll; R L Summers; D J Dzielak; K Cockrell; J P Montani; H L Mizelle
Journal:  Hypertension       Date:  1999-03       Impact factor: 10.190

Review 5.  Abnormal kidney function as a cause and a consequence of obesity hypertension.

Authors:  J E Hall; M W Brands; J R Henegar; E W Shek
Journal:  Clin Exp Pharmacol Physiol       Date:  1998-01       Impact factor: 2.557

6.  Chronic leptin infusion increases arterial pressure.

Authors:  E W Shek; M W Brands; J E Hall
Journal:  Hypertension       Date:  1998-01       Impact factor: 10.190

7.  Role of melanocortinergic neurons in feeding and the agouti obesity syndrome.

Authors:  W Fan; B A Boston; R A Kesterson; V J Hruby; R D Cone
Journal:  Nature       Date:  1997-01-09       Impact factor: 49.962

8.  Is there a role for the ob gene product leptin in essential hypertension?

Authors:  P M Suter; R Locher; E Häsler; W Vetter
Journal:  Am J Hypertens       Date:  1998-11       Impact factor: 2.689

9.  Importance of obesity, race and age to the cardiac structural and functional effects of hypertension. The Department of Veterans Affairs Cooperative Study Group on Antihypertensive Agents.

Authors:  J S Gottdiener; D J Reda; B J Materson; B M Massie; A Notargiacomo; R J Hamburger; D W Williams; W G Henderson
Journal:  J Am Coll Cardiol       Date:  1994-11-15       Impact factor: 24.094

10.  Increased hyaluronic acid in the inner renal medulla of obese dogs.

Authors:  M Alonso-Galicia; T M Dwyer; G A Herrera; J E Hall
Journal:  Hypertension       Date:  1995-04       Impact factor: 10.190

View more
  40 in total

Review 1.  The metabolic syndrome and related cardiovascular risk.

Authors:  F Ramos; H P Baglivo; A J Ramírez; R Sánchez
Journal:  Curr Hypertens Rep       Date:  2001-04       Impact factor: 5.369

2.  Angiotensin AT1 and AT2 receptor antagonists modulate nicotine-evoked [³H]dopamine and [³H]norepinephrine release.

Authors:  Vidya Narayanaswami; Sucharita S Somkuwar; David B Horton; Lisa A Cassis; Linda P Dwoskin
Journal:  Biochem Pharmacol       Date:  2013-07-04       Impact factor: 5.858

Review 3.  The Role of Sympatho-Inhibition in Combination Treatment of Obesity-Related Hypertension.

Authors:  Revathy Carnagarin; Cynthia Gregory; Omar Azzam; Graham S Hillis; Carl Schultz; Gerald F Watts; Damon Bell; Vance Matthews; Markus P Schlaich
Journal:  Curr Hypertens Rep       Date:  2017-10-28       Impact factor: 5.369

Review 4.  Stress and salt sensitivity in primary hypertension.

Authors:  Deborah L Stewart; Gregory A Harshfield; Haidong Zhu; Coral D Hanevold
Journal:  Curr Hypertens Rep       Date:  2015-02       Impact factor: 5.369

Review 5.  Endoscopic Bariatric Therapies.

Authors:  Deepinder Goyal; Rabindra R Watson
Journal:  Curr Gastroenterol Rep       Date:  2016-06

Review 6.  Cardiovascular Risk in Patients with Prehypertension and the Metabolic Syndrome.

Authors:  Sergey Kachur; Rebecca Morera; Alban De Schutter; Carl J Lavie
Journal:  Curr Hypertens Rep       Date:  2018-03-06       Impact factor: 5.369

7.  Obesity-hypertension and its relation to other diseases in dogs.

Authors:  Alicia Pamela Pérez-Sánchez; Javier Del-Angel-Caraza; Israel Alejandro Quijano-Hernández; Marco Antonio Barbosa-Mireles
Journal:  Vet Res Commun       Date:  2015-02-10       Impact factor: 2.459

8.  Prevalence and correlates of sustained hypertension in adolescents of rural Wardha, central India.

Authors:  Jitendra Kumar; Pradeep R Deshmukh; Bishan S Garg
Journal:  Indian J Pediatr       Date:  2011-12-29       Impact factor: 1.967

9.  Obesity, Hypertension, and Dyslipidemia in Childhood Are Key Modifiable Antecedents of Adult Cardiovascular Disease: A Call to Action.

Authors:  Christy B Turer; Tammy M Brady; Sarah D de Ferranti
Journal:  Circulation       Date:  2018-03-20       Impact factor: 29.690

10.  Medical complications of obesity and optimization of the obese patient for colorectal surgery.

Authors:  Nell Maloney Patel; Manish S Patel
Journal:  Clin Colon Rectal Surg       Date:  2011-12
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.